Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 28, 2020

SELL
$16.88 - $20.83 $6,380 - $7,873
-378 Closed
0 $0
Q3 2019

Oct 25, 2019

BUY
$16.15 - $17.99 $32 - $35
2 Added 0.53%
378 $65,000
Q1 2019

Apr 09, 2019

BUY
$16.7 - $21.52 $6,279 - $8,091
376 New
376 $8,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Quad Cities Investment Group, LLC Portfolio

Follow Quad Cities Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quad Cities Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quad Cities Investment Group, LLC with notifications on news.